Back to results
US 2026/0168991 A1Published application
Method for detection of pesticides using peptide sequences
AssigneeImam Abdulrahman Bin Faisal University
InventorSarah ALDULAIJAN
Life of this patent
Estimating the term…
Abstract
Aspects of the present disclosure are directed to a method for detection of pesticides using peptides. The method includes contacting at least one peptide, selected from a group consisting of YSM21, PSM22, PSW31, and WQA34, with a sample comprising a pesticide. The peptide comprises a fluorescent probe and the pesticide is imidacloprid. The method further includes binding the pesticide to the peptide to form an analyte composition and detecting the pesticide based on a fluorescence spectrum of the analyte composition.
Claims20
1:
- A method of pesticide detection, comprising:
- contacting at least one peptide with a sample comprising a pesticide,
- wherein the peptide is selected from a group consisting of YSM21, PSM22, PSW31, and WQA34,
- wherein the YSM21 peptide has an amino acid sequence at least 85% identical to SEQ. ID No.:
- 1,
- wherein the PSM22 peptide has an amino acid sequence at least 85% identical to SEQ. ID No.:
- 2,
- wherein the PSW31 peptide has an amino acid sequence at least 85% identical to SEQ. ID No.:
- 3,
- wherein the WQA34 peptide has an amino acid sequence at least 85% identical to SEQ. ID No.:
- 4,
- wherein the peptide comprises a fluorescent probe,
- wherein the pesticide is imidacloprid,
- binding the pesticide to the peptide to form an analyte composition;
- and
- detecting the pesticide based on a fluorescence spectrum of the analyte composition.
13 more elements
2:
- The method of claim 1, wherein the peptide has a binding affinity for imidacloprid of −3 to −6 kcal/mol.
3:
- The method of claim 1, wherein the peptide is WQA34, and a hydroxyl group of the imidacloprid interacts with a tryptophan in a sixth position of the WQA34 during the binding.
4:
- The method of claim 1, wherein the peptide is WQA34, and a benzene ring of the imidacloprid interacts with a tryptophan in a thirty fourth position of the WQA34 during the binding.
5:
- The method of claim 1, wherein the peptide is WQA34, and a chloride atom of the imidacloprid interacts with a tryptophan in a thirty fourth position of the WQA34 and a proline in a fifteenth position of the WQA34 during the binding.
6:
- The method of claim 1, wherein the peptide is WQA34, and the peptide has an average binding free energy of −7 to −6 kcal/mol to the imidacloprid during the binding.
7:
- The method of claim 1, wherein the peptide is WQA34, and the peptide has an average free energy of solvated receptor-ligand binding of −6 to −4 kcal/mol to the imidacloprid during the binding.
8:
- The method of claim 1, wherein the peptide is WQA34, and the peptide has an equilibrium dissociation constant of 30 to 50 μM to the imidacloprid during the binding.
9:
- The method of claim 1, wherein the peptide is WQA34, and a root mean square deviation value of the peptide associated with the imidacloprid during the binding is 70 to 80% less compared to a root mean square value of the peptide not associated with the imidacloprid during the binding.
10:
- The method of claim 1, wherein the peptide is PSW31, and a root mean square deviation value of the peptide associated with the imidacloprid during the binding is 45 to 55% less compared to a root mean square value of the peptide not associated with the imidacloprid during the binding.
11:
- The method of claim 1, further comprising:
- binding the peptide to acetamiprid and clothianidin.
12:
- The method of claim 11, wherein the peptide is WQA34, and the peptide has an average free energy of −3 to −1 kcal/mol for acetamiprid during the binding.
13:
- The method of claim 11, wherein the peptide is WQA34, and the peptide has an average free energy of −2 to 0 kcal/mol for clothianidin during the binding.
14:
- The method of claim 1, wherein the peptide is YSM21 and has an amino acid sequence at least 95% identical to SEQ. ID No.:
- 1.
15:
- The method of claim 1, wherein the peptide is PSM22 and has an amino acid sequence at least 95% identical to SEQ. ID No.:
- 2.
16:
- The method of claim 1, wherein the peptide is PSW31 and has an amino acid sequence at least 95% identical to SEQ. ID No.:
- 3.
17:
- The method of claim 1, wherein the peptide is WQA34 and has an amino acid sequence at least 90% identical to SEQ. ID No.:
- 4.
18:
- 18:
- The method of claim 1, wherein the peptide is WQA34 and has an amino acid sequence at least 95% identical to SEQ. ID No.:
- 4.
19:
- The method of claim 1, wherein the peptide is WQA34 and has an amino acid sequence at least 99% identical to SEQ. ID No.:
- 4.
20:
- The method of claim 1, wherein the peptide is PSW31, and the peptide has an equilibrium dissociation constant of 30,000 to 40,000 μM to the imidacloprid during the binding.